HemoCath Ltd. is an early-stage Canadian/Irish company that has developed over the past 7 years novel medical devices called HemoCath PA catheters and HemoCath Heart Failure Monitoring Platform. These proprietary solutions address large unmet clinical needs for PAP-guided diagnostics, monitoring and therapies for patients with heart failure (PAP: pulmonary artery pressure). HemoCath-guided heart failure management will soon become the standard of care – reducing hospital length of stay and rehospitalization for heart failure patients.
Company’s Keywords:
<3
<
<2014